(Q38293726)

1 September 2017

title

Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells (English)

1 reference

1 September 2017

0 references

Valentino Bezzerri

1

1 reference

1 September 2017

Monica Borgatti

2

1 reference

1 September 2017

Elena Nicolis

3

1 reference

1 September 2017

Ilaria Lampronti

4

1 reference

1 September 2017

Maria Cristina Dechecchi

5

1 reference

1 September 2017

Irene Mancini

6

1 reference

1 September 2017

Paolo Rizzotti

7

1 reference

1 September 2017

Roberto Gambari

8

1 reference

1 September 2017

Giulio Cabrini

9

1 reference

1 September 2017

publication date

7 February 2008

1 reference

American Journal of Respiratory Cell and Molecular Biology

1 September 2017

published in

1 reference

1 September 2017

volume

39

1 reference

1 September 2017

issue

1

1 reference

1 September 2017

page(s)

86-96

1 reference

New concepts of the pathogenesis of cystic fibrosis lung disease

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Innate immune response in CF airway epithelia: hyperinflammatory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Inflammatory cytokines in cystic fibrosis lungs

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Cytokine production by cultured human bronchial epithelial cells infected with a replication-deficient adenoviral gene transfer vector or wild-type adenovirus type 5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Lung inflammation as a therapeutic target in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Pharmacological approaches for the discovery and development of new anti-inflammatory agents for the treatment of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

NF-kappaB activation and sustained IL-8 gene expression in primary cultures of cystic fibrosis airway epithelial cells stimulated with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Transcription factor decoys: a new model for disease intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Therapeutic applications of transcription factor decoy oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Biological activity and delivery of peptide nucleic acids (PNA)-DNA chimeras for transcription factor decoy (TFD) pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Interaction of the human NF-kappaB p52 transcription factor with DNA-PNA hybrids mimicking the NF-kappaB binding sites of the human immunodeficiency virus type 1 promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Decoy oligodeoxynucleotides targeting NF-kappaB transcription factors: induction of apoptosis in human primary osteoclasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Attenuation of interleukin-8 production by inhibiting nuclear factor-kappaB translocation using decoy oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Anti-inflammatory gene therapy directed at the airway epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Cytoplasmic deposition of NFkappaB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Novel pharmacologic therapies for cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Reverse transcription-polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands, and lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Pseudomonas aeruginosa Flagella Activate Airway Epithelial Cells through asialoGM1 and Toll-Like Receptor 2 as well as Toll-Like Receptor 5

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

AsialoGM1 and TLR5 cooperate in flagellin-induced nucleotide signaling to activate Erk1/2

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Flagellar activation of epithelial signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Prevention of neutrophil migration ameliorates rat lung allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Therapeutic effect of in vivo transfection of transcription factor decoy to NF-kappaB on septic lung in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Peptide nucleic acids (PNA)-DNA chimeras targeting transcription factors as a tool to modify gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

New trends in the development of transcription factor decoy (TFD) pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Complexation to cationic microspheres of double-stranded peptide nucleic acid-DNA chimeras exhibiting decoy activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1165%2FRCMB.2007-0176OC

21 January 2018

Identifiers

DOI

10.1165/RCMB.2007-0176OC

1 reference

1 September 2017

1 reference